vs
Side-by-side financial comparison of GYRE THERAPEUTICS, INC. (GYRE) and Postal Realty Trust, Inc. (PSTL). Click either name above to swap in a different company.
GYRE THERAPEUTICS, INC. is the larger business by last-quarter revenue ($37.2M vs $26.0M, roughly 1.4× Postal Realty Trust, Inc.). Postal Realty Trust, Inc. runs the higher net margin — 17.9% vs -3.7%, a 21.5% gap on every dollar of revenue. On growth, GYRE THERAPEUTICS, INC. posted the faster year-over-year revenue change (33.4% vs 21.7%). Postal Realty Trust, Inc. produced more free cash flow last quarter ($37.6M vs $-5.8M). Over the past eight quarters, Postal Realty Trust, Inc.'s revenue compounded faster (22.6% CAGR vs 17.0%).
GYRE Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel targeted therapies for hard-to-treat hematologic malignancies and solid tumors. It focuses on precision oncology to address unmet patient needs, with operations primarily based in North America.
Postal Realty Trust, Inc. is a specialized real estate investment trust that acquires, owns, and manages properties primarily leased to the United States Postal Service. Its portfolio includes last-mile postal facilities, sorting centers, and retail post office locations across the U.S., supporting critical mail and package delivery infrastructure.
GYRE vs PSTL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $37.2M | $26.0M |
| Net Profit | $-1.4M | $4.6M |
| Gross Margin | 95.3% | — |
| Operating Margin | 0.3% | 39.2% |
| Net Margin | -3.7% | 17.9% |
| Revenue YoY | 33.4% | 21.7% |
| Net Profit YoY | -340.1% | 3.1% |
| EPS (diluted) | $-0.01 | $0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $37.2M | $26.0M | ||
| Q3 25 | $30.6M | $24.3M | ||
| Q2 25 | $26.8M | $23.4M | ||
| Q1 25 | $22.1M | $22.1M | ||
| Q4 24 | $27.9M | $21.4M | ||
| Q3 24 | $25.5M | $19.7M | ||
| Q2 24 | $25.2M | $18.1M | ||
| Q1 24 | $27.2M | $17.3M |
| Q4 25 | $-1.4M | $4.6M | ||
| Q3 25 | $5.9M | $3.8M | ||
| Q2 25 | $1.6M | $3.6M | ||
| Q1 25 | $3.7M | $2.1M | ||
| Q4 24 | $569.0K | $4.5M | ||
| Q3 24 | $2.9M | $1.1M | ||
| Q2 24 | $4.5M | $817.0K | ||
| Q1 24 | $9.9M | $206.0K |
| Q4 25 | 95.3% | — | ||
| Q3 25 | 94.7% | — | ||
| Q2 25 | 95.7% | — | ||
| Q1 25 | 95.9% | — | ||
| Q4 24 | 95.8% | — | ||
| Q3 24 | 96.2% | — | ||
| Q2 24 | 96.9% | — | ||
| Q1 24 | 96.4% | — |
| Q4 25 | 0.3% | 39.2% | ||
| Q3 25 | 22.7% | 37.6% | ||
| Q2 25 | 8.1% | 37.3% | ||
| Q1 25 | 10.3% | 28.4% | ||
| Q4 24 | 2.4% | 43.2% | ||
| Q3 24 | 16.6% | 24.3% | ||
| Q2 24 | 12.7% | 22.8% | ||
| Q1 24 | 29.7% | 17.6% |
| Q4 25 | -3.7% | 17.9% | ||
| Q3 25 | 19.4% | 15.7% | ||
| Q2 25 | 5.9% | 15.5% | ||
| Q1 25 | 16.9% | 9.4% | ||
| Q4 24 | 2.0% | 21.1% | ||
| Q3 24 | 11.2% | 5.4% | ||
| Q2 24 | 18.0% | 4.5% | ||
| Q1 24 | 36.6% | 1.2% |
| Q4 25 | $-0.01 | $0.16 | ||
| Q3 25 | $0.03 | $0.13 | ||
| Q2 25 | $0.00 | $0.12 | ||
| Q1 25 | $0.00 | $0.06 | ||
| Q4 24 | $0.00 | $0.17 | ||
| Q3 24 | $0.01 | $0.03 | ||
| Q2 24 | $0.01 | $0.02 | ||
| Q1 24 | $0.03 | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $52.4M | $1.5M |
| Total DebtLower is stronger | — | $361.1M |
| Stockholders' EquityBook value | $106.0M | $285.2M |
| Total Assets | $166.1M | $759.1M |
| Debt / EquityLower = less leverage | — | 1.27× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.4M | $1.5M | ||
| Q3 25 | $60.0M | $1.9M | ||
| Q2 25 | $54.4M | $1.1M | ||
| Q1 25 | $29.9M | $639.0K | ||
| Q4 24 | $26.7M | $1.8M | ||
| Q3 24 | $25.1M | $970.0K | ||
| Q2 24 | $25.1M | $1.7M | ||
| Q1 24 | $37.4M | $1.9M |
| Q4 25 | — | $361.1M | ||
| Q3 25 | — | $347.0M | ||
| Q2 25 | — | $328.8M | ||
| Q1 25 | — | $306.7M | ||
| Q4 24 | — | $296.7M | ||
| Q3 24 | — | $277.0M | ||
| Q2 24 | — | $273.7M | ||
| Q1 24 | — | $247.6M |
| Q4 25 | $106.0M | $285.2M | ||
| Q3 25 | $101.9M | $273.9M | ||
| Q2 25 | $92.0M | $250.8M | ||
| Q1 25 | $68.1M | $245.5M | ||
| Q4 24 | $63.3M | $251.3M | ||
| Q3 24 | $63.2M | $245.6M | ||
| Q2 24 | $60.4M | $245.5M | ||
| Q1 24 | $56.6M | $248.1M |
| Q4 25 | $166.1M | $759.1M | ||
| Q3 25 | $159.4M | $735.2M | ||
| Q2 25 | $152.6M | $689.8M | ||
| Q1 25 | $129.8M | $654.0M | ||
| Q4 24 | $125.4M | $646.8M | ||
| Q3 24 | $125.2M | $615.1M | ||
| Q2 24 | $120.9M | $608.2M | ||
| Q1 24 | $122.0M | $584.1M |
| Q4 25 | — | 1.27× | ||
| Q3 25 | — | 1.27× | ||
| Q2 25 | — | 1.31× | ||
| Q1 25 | — | 1.25× | ||
| Q4 24 | — | 1.18× | ||
| Q3 24 | — | 1.13× | ||
| Q2 24 | — | 1.11× | ||
| Q1 24 | — | 1.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.6M | $44.5M |
| Free Cash FlowOCF − Capex | $-5.8M | $37.6M |
| FCF MarginFCF / Revenue | -15.5% | 144.5% |
| Capex IntensityCapex / Revenue | 0.4% | 26.7% |
| Cash ConversionOCF / Net Profit | — | 9.59× |
| TTM Free Cash FlowTrailing 4 quarters | $-180.0K | $65.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.6M | $44.5M | ||
| Q3 25 | $4.7M | $10.9M | ||
| Q2 25 | $2.1M | $11.4M | ||
| Q1 25 | $-129.0K | $10.8M | ||
| Q4 24 | $-2.8M | $33.5M | ||
| Q3 24 | $1.7M | $8.0M | ||
| Q2 24 | $-5.5M | $9.9M | ||
| Q1 24 | $2.9M | $6.4M |
| Q4 25 | $-5.8M | $37.6M | ||
| Q3 25 | $4.0M | $8.8M | ||
| Q2 25 | $1.8M | $9.1M | ||
| Q1 25 | $-251.0K | $10.2M | ||
| Q4 24 | $-2.8M | $30.7M | ||
| Q3 24 | $1.0M | $7.4M | ||
| Q2 24 | $-6.9M | $8.9M | ||
| Q1 24 | $2.7M | $5.8M |
| Q4 25 | -15.5% | 144.5% | ||
| Q3 25 | 13.1% | 36.1% | ||
| Q2 25 | 6.8% | 38.8% | ||
| Q1 25 | -1.1% | 45.9% | ||
| Q4 24 | -10.1% | 143.8% | ||
| Q3 24 | 4.1% | 37.6% | ||
| Q2 24 | -27.5% | 49.4% | ||
| Q1 24 | 9.8% | 33.6% |
| Q4 25 | 0.4% | 26.7% | ||
| Q3 25 | 2.2% | 8.9% | ||
| Q2 25 | 1.0% | 10.1% | ||
| Q1 25 | 0.6% | 3.0% | ||
| Q4 24 | 0.2% | 13.0% | ||
| Q3 24 | 2.7% | 3.2% | ||
| Q2 24 | 5.8% | 5.4% | ||
| Q1 24 | 0.9% | 3.5% |
| Q4 25 | — | 9.59× | ||
| Q3 25 | 0.79× | 2.87× | ||
| Q2 25 | 1.32× | 3.16× | ||
| Q1 25 | -0.03× | 5.20× | ||
| Q4 24 | -4.85× | 7.44× | ||
| Q3 24 | 0.60× | 7.48× | ||
| Q2 24 | -1.21× | 12.10× | ||
| Q1 24 | 0.29× | 31.07× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
